Women harboring a loss-of-function mutation in the PALB2 gene demonstrated an increased risk of developing breast cancer that was similar to the predisposition seen with mutations in the infamous BRCA gene, according to a study published in The New England Journal of Medicine (NEJM).
According to a new study, most women aged 65 and older with non-metastatic breast cancer adhered to their hormone therapy.
A new study led by researchers at the Perelman School of Medicine at the University of Pennsylvania has shown that electroacupuncture produces significant improvements in fatigue, anxiety, and depression in as little as 8 weeks for early-stage breast cancer patients experiencing joint pain related to the use of aromatase inhibitors (AIs).
Taking the breast cancer journey with someone who's been "in your shoes"
Deirdre Kiely, MS, MPA, RN, ANP, nurse practitioner, Perlmutter Cancer Center at NYU Langone Medical Center, discusses the results of a breast cancer lifestyle intervention study.
Cardiac events associated with trastuzumab (Herceptin) are mostly reversible and outweighed by significant extensions in overall survival (OS) and progression-free survival (PFS) for patients with HER2-positive breast cancer
This college admissions essay, penned by 17-year-old Samantha Stephens, offers a powerful and poignant reminder of the impact a cancer diagnosis can have on a patient's family and caregivers.
Reshma Jagsi, MD, DPhil, associate professor, Department of Radiation Oncology, University of Michigan Health System, discusses an analysis of the adoption of hypofractionated radiotherapy for early-stage invasive breast cancer.
The majority of women with breast cancer who undergo the recommended genetic testing for BRCA1/2 mutations and test positive prior to undergoing surgery will change their surgical plan to include a more extensive procedure, a new study reports.
A pilot study of an educational and behavioral program conducted by researchers at the New York University College of Nursing has successfully reduced the risk of lymphedema in breast cancer patients who have undergone axillary lymph node dissection or sentinel lymph node biopsy.
A new study published today online in CANCER shows that the majority of breast cancer patients did not meet national physical activity guidelines after they were diagnosed
A recent survey conducted by the National Society of Genetic Counselors (NSGC) showed a significant increase in patient calls and requests for testing and referrals from healthcare providers in the year following actress Angelina Jolie's announcement of her BRCA mutation status and subsequent double mastectomy.
Arin Ahlum Hanson, MPH, CHES, manager, Young Women's Initiative, Living Beyond Breast Cancer, discusses the unique needs of young women who are affected by breast cancer.
Phase III trial results presented at the 2014 ASCO Annual Meeting showed that the dosing frequency of zoledronic acid (Zometa) can be reduced by 67% without compromising effectiveness in women with breast cancer and bone metastases, potentially lowering the risk of serious adverse events.
Adjuvant exemestane reduced the relative risk of developing subsequent invasive cancer in hormone-receptor–positive (HR+) premenopausal women by 28% compared with tamoxifen when both agents were combined with ovarian function suppression (OFS)
A new study presented at the 2014 ASCO Annual Meeting has found that adding goserelin to chemotherapy for women with early-stage hormone receptor (HR)-negative breast cancer helps both to preserve their fertility and to prolong their survival.
The ASCO clinical practice guideline now recommends treatment with adjuvant tamoxifen for 10 years in women with stage I-III hormone receptor (HR)-positive breast cancer.
Nobody Is Listening: Stories of Inflammatory Breast Cancer chronicles the accounts of women affected by inflammatory breast cancer, the most aggressive type of breast cancer.
An analysis of a large, nationwide dataset has revealed that regardless of their socioeconomic status, black women are nearly twice as likely to be diagnosed with triple-negative breast cancer (TNBC) and Asian/Pacific Islander women are more likely to be diagnosed with HER2-overexpressing breast cancer compared with white women.
Sexual problems, such as loss of desire, failure to get aroused easily, and vaginal dryness and pain during sexual activity, are prevalent among breast cancer survivors, and they rarely go away without treatment.
Obesity significantly increases the risk of dying of breast cancer in premenopausal women with ER-positive early disease, according to findings from a large, retrospective study involving 80,000 patients.
Healthcare providers are expected to advise patients about the potential effects of cancer treatment, including impact on fertility. In many facilities, it's a required component of the informed consent process.
Nurses at the Rutgers Cancer Institute of New Jersey have developed a program to help patients with early-stage breast cancer to better understand and retain information about their presurgical treatments.
Low sexual desire is a common problem among women diagnosed with breast cancer, ranking as one of the top three causes of post cancer distress
Archana Ajmera, RN, MSN, WHNP-BC, ANP-BC, nurse practitioner, University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, discusses stomatitis prevention during everolimus/exemestane treatment for metastatic breast cancer.
